CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Opyl Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Opyl Ltd
Engine House, 105 Wellington Street
Phone: +61 894209300p:+61 894209300 ST KILDA, VIC  3182  Australia Ticker: OPLOPL
Business Summary
Opyl Limited is an Australia-based company that provides biopharma and health organizations access to artificial intelligence (AI)-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery. It has two core business streams: services and technologies. Its technology research and development pipeline provide life science developers and healthcare providers with unprecedented insight and data optimization opportunities. It has three key platforms in development that utilize artificial intelligence to analyze structured and unstructured data to deliver high value insights. Its platforms include clinical trial prediction and protocol design tool, clinical trial recruitment tool (Opin) and deep social media insights in healthcare. Its core services accessible at it include clinical trial recruitment, social media insights, market research and analysis and training and workshops. Its Opin is a clinical trial recruitment platform.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20236/30/2023Yes----

Industries
SIC Code Description
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board MarkZiirsen 59 1/1/2022 9/21/2020
Interim Chief Executive Officer SaurabhJain 11/24/2023 11/24/2023
Executive Director DamonRasheed 9/21/2020 2/1/2019
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Monto Minerals Ltd
OPL
SRO
SRODC
SRODD

General Information
Number of Employees: 3 (As of 6/30/2005)
Outstanding Shares: 124,527,257 (As of 12/31/2023)
Shareholders: 2,753
Stock Exchange: ASX
Fax Number: +61 894812690


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024